Instem Participates in SEND Panel Program Sponsored by the Pistoia Alliance
Pistoia Alliance Debates Webinar Reviewing Key Principles of FDA-Adopted CDISC Preclinical Standard
CONSHOHOCKEN, PA – March 17, 2016 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has participated in a Webinar organized by the Pistoia Alliance, which took place on March 16th.
The webinar, part of the “Pistoia Alliance Debates” series, introduced the audience to the key principles of SEND. Using web-based presentations and discussion, the webinar panel members outlined how efficient management, exchange and submission of non-clinical development study data can be implemented using SEND.
Furthermore, the webinar identified some of the key, due-diligence questions that need to be addressed before considering exchanging information with other companies in the information ecosystem including CROs.
Along with key industry leaders from Sanofi, Bristol-Myers Squibb and Merck KGaA, Instem’s Vice President of Regulatory Submissions and CDISC/SEND Team Leader Lou Ann Kramer participated in this program as a panelist.
Additional details about the Pistoia Alliance can be found at:
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600